1. 37LBA Telotristat etiprate is effective in treating patients with carcinoid syndrome that is inadequately controlled by somatostatin analog therapy (the phase 3 TELESTAR clinical trial). (September 2015) Authors: Kulke, M.H.; Horsch, D.; Caplin, M.; Anthony, L.; Bergsland, E.; Oberg, K.; Welin, S.; Warner, R.; Lombard-Bohas, C.; Kunz, P.; Grande, E.; Valle, J.; Fleming, D.; Lapuerta, P.; Banks, P.; Jackson, S.; Wheeler, D.; Zambrowicz, B.; Sands, A.; Pavel, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S728 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A falls prevention program for people with ms who fall: a feasibility pre-post intervention design. (May 2015) Authors: Lennon, S.; Anthony, L.; Burnell, S.; Ventoruzzo, S.; Bradnam, L. Journal: Physiotherapy Issue: Volume 101(2016)Supplement 1 Page Start: e858 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗